Why is Bliss GVS Pharma falling/rising?

As of 12-Aug, Bliss GVS Pharma Ltd's stock price is currently at 174.65, reflecting an increase of 1.35, or 0.78%. The stock has shown a trend reversal by gaining after two consecutive days of decline, opening with a significant gain of 3.58% today and reaching an intraday high of Rs 179.5. Despite this positive movement, the stock has underperformed the benchmark Sensex over the past week, with a decline of 2.65% compared to the Sensex's 0.59%. However, over the past month, Bliss GVS Pharma has outperformed the Sensex, gaining 13.41% while the benchmark fell by 2.75%. The stock's long-term performance remains strong, with a 55.45% return over the past year and a 127.85% increase over the past three years, although profits have decreased by 3.6% during the same period.
In the broader market context, the stock's recent performance has been notable as it has outperformed the BSE500 in both the long term and near term, indicating a strong market position. However, the stock's delivery volume has fallen significantly, by 55.27% against the 5-day average, suggesting a decline in investor participation. Despite a low debt-to-equity ratio and a fair valuation, the stock is trading at a premium compared to its peers, which may affect investor sentiment. Overall, while the stock is currently rising, the decrease in delivery volume and falling profits could pose challenges for sustained growth in the near future.